Tiny study probes GIP's role in gut blood flow for diabetes
NCT ID NCT06426823
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed study looked at how the hormone GIP changes blood flow in the gut after a sugary drink in 10 people with type 2 diabetes. Researchers used a GIP-blocking drug to see what happens when GIP is stopped. The goal was to better understand GIP's role in digestion and metabolism, not to test a new treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- GIP(3-30)NH2 (a GIP receptor blocker) and saline placebo
- What this could lead to
- If successful, this could clarify how GIP influences digestion and metabolism in type 2 diabetes, potentially guiding future treatments.
- What could go wrong
- This is a very small, completed study (10 people) focused on understanding basic mechanisms, not testing a treatment. Results may not apply broadly.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLOOD FLOW are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Rigshospitalet
Copenhagen, 2200, Denmark
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Sound waves during bypass surgery could save grafts
- MRI study aims to unravel why some people feel dizzy after eating
- Space Travel's hidden effect on Women's bodies: new study reveals clues
- Aging Women's blood flow secrets revealed in new study
- Citrus compound could be the next workout and brain booster
- Can heat and suction boost foot blood flow? new study investigates